June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Helena Linardou: Pivotal Paper on Tarlatamab in 2nd Line SCLC by Giannis Mountzios and Colleagues
Jun 3, 2025, 12:16

Helena Linardou: Pivotal Paper on Tarlatamab in 2nd Line SCLC by Giannis Mountzios and Colleagues

Helena Linardou, Director of the 4th Oncology Department and the Comprehensive Clinical Trials Center at Metropolitan Hospital, shared a post on LinkedIn:

“A significant milestone for oncology and a moment of exceptional pride!
The NEJM has just published a pivotal paper on Tarlatamab in second-line small-cell lung cancer (SCLC) – with my dear friend and colleague Giannis Mountzios as first author.

This achievement marks:

• A breakthrough for patients with few treatment options,
• A moment of recognition for Greek oncology on the global research stage, and
• A personal triumph for someone whose dedication to science and patient care is second to none.
Huge congratulations, Giannis Mountzios, your work continues to push the field forward and inspire so many of us.
Sooo happy and super proud of you!!”

Title: Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy

Authors: Giannis Mountzios, Longhua Sun, Byoung Chul Cho, Umut Demirci, Sofia Baka, Mahmut Gümüş, Antonio Lugini, Bo Zhu, Yan Yu, Ippokratis Korantzis, Ji-Youn Han, Tudor-Eliade Ciuleanu, Myung-Ju Ahn, Pedro Rocha, Julien Mazières, Sally C.M. Lau, Martin Schuler, Fiona Blackhall, Tatsuya Yoshida, Taofeek K. Owonikoko, Luis Paz-Ares, Tony Jiang, Ali Hamidi, Diana Gauto, Gonzalo Recondo, Charles M. Rudin

Read Full Article.

Tarlatamab

Read OncoDaily’s Special Articles:

Tarlatamab (Imdelltra): What Patients Need to Know About

Tarlatamab (Imdelltra): Uses in Cancer, Side Effects, Dosages, Expectations, and More

Tarlatamab